Kangmei Pharma | 600518 - Current Liabilities



Kangmei Pharma reported CNY5.75B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Alaunos Therapeutics USD 4K 822K Oct/2024
Avita Medical AUD 20.16M 6.37M Dec/2024
Cspc Pharmaceutical CNY 9.63B 801.28M Dec/2024
Dianthus Therapeutics USD 20.09M 1.64M Jun/2025
Genomma Lab Internacional MXN 7.27B 1.13B Jun/2025
Hypermarcas BRL 4.44B 223.67M Jun/2025
Ionis Pharmaceuticals USD 897.24M 646.94M Jun/2025
IQVIA Holdings USD 7.57B 393M Jun/2025
Jiangsu Hengrui CNY 3.47B 102.17M Jun/2025
Kangmei Pharma CNY 5.75B 64.58M Jun/2025
Moderna USD 1.57B 32M Jun/2025
Organon & Co USD 2.8B 181M Jun/2025
Revvity USD 671.81M 23.63M Jun/2025
Sh Fosun Pharma CNY 36.02B 522.8M Jun/2025
Tectonic Therapeutic USD 11.36M 250K Jun/2025
Viatris USD 7.13B 1.41B Jun/2025
Wuxi Apptec CNY 20.52B 1.65B Jun/2025
Xeris Pharmaceuticals USD 95.17M 5.27M Jun/2025
Zz Pientze Pharmaceu 3.2B 878.89M Jun/2025